NCT03121820 - Fasting Bioequivalence Study of Memantinol 20 mg Tablets Versus Akatinol Memantine® 20 mg Tablets In Normal Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 11, 2016

Primary Completion Date

November 19, 2016

Study Completion Date

November 19, 2016

Conditions

Bioequivalence, AUC, Cmax, Pharmacokinetics

Interventions

DRUG

Memantinol tablets, 20 mg

"Bioequivalence Memantine Hydrochloride (JSC GEROPHARM, Russia) 20 mg film-coated tablets fasting condition"

DRUG

Akatinol Memantine® tablets, 20 mg

Bioequivalence Memantine Hydrochloride (Merz Pharma GmbH \& Co. KGaA, Germany) 20 mg film-coated tablets fasting condition

Trial Locations (1)

City Clinical Hospital № 15 named. O.M.filatova, Moscow